UK Biotechnology Market
Updated Date: 17 July 2026   |   Report Code: 6912
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

UK Biotechnology Market Accelerate Next-Gen Life Sciences

According to Payal Rabde, who specializes in biotechnology and life sciences research, with 4+ years of experience in market research and industry analysis. My research indicates that the UK biotechnology market size was estimated at USD 113.41 billion in 2025 and is predicted to increase from USD 126.45 billion in 2026 to approximately USD 336.82 billion by 2035, expanding at a CAGR of 11.5% from 2026 to 2035, driven by growing research in biotechnology, government support, and collaborations among key players. The competitive landscape features major players such as AstraZeneca, GlaxoSmithKline (GSK), Oxford Biomedica, Evotec (UK operations), and Abcam.

Last Updated : 17 July 2026 Category: Biotechnology Insight Code: 6912 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global UK Biotechnology  Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global UK Biotechnology  Market Analysis, By Technology
    • Market Size, Forecast & CAGR,By Product Type 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global UK Biotechnology  Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global UK Biotechnology  Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global UK Biotechnology Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America UK Biotechnology  Market Analysis
  • North America UK Biotechnology  Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America UK Biotechnology Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America UK Biotechnology Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America UK Biotechnology Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America UK Biotechnology  Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. UK Biotechnology  Market Analysis
    • U.S. UK Biotechnology  Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. UK Biotechnology Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. UK Biotechnology Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. UK Biotechnology Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Technology
      • By Application
      • By End User
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Oxford Biomedica
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Autolus Therapeutics
    • Adaptimmune Therapeutics
    • Verona Pharma
    • Immunocore
    • Orchard Therapeutics
    • Silence Therapeutics
    • Bicycle Therapeutics
    • Touchlight
    • Abcam
    • Vaccitech
    • Avacta Group

FAQ's

Answer : The UK biotechnology market in 2026 is valued at USD 126.45 billion and is projected to climb to USD 336.82 billion by 2035, with a CAGR of 11.5% over the forecast period.

Answer : The UK biotechnology market includes 4 segments by product, by technology, by application, and by end user.

Answer : National Institutes of Health, FDA, WHO, PIB, UK.GOV, UK Parliament.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar